| Literature DB >> 31471054 |
Christopher J Farrell1, Tomas Garzon-Muvdi2, Judd H Fastenberg3, Gurston G Nyquist3, Mindy R Rabinowitz3, Marc R Rosen3, James J Evans2.
Abstract
Pituitary adenomas are typically slow-growing benign tumors. However, 50% to 60% of tumors progress following subtotal resection and up to 30% recur after apparent complete resection. Options for treatment of recurrent pituitary adenomas include repeat surgical resection, radiation therapy, and systemic therapies. There is no consensus approach for the management of recurrent pituitary adenomas. This article reviews the natural history of recurrent adenomas and emerging biomarkers predictive of clinical behavior as well as the outcomes associated with the various treatment modalities for these challenging tumors, with an emphasis on the surgical treatment.Entities:
Keywords: KNOSP grade; Pituitary adenomas; Recurrent pituitary tumor; Transsphenoidal surgery
Mesh:
Year: 2019 PMID: 31471054 DOI: 10.1016/j.nec.2019.05.006
Source DB: PubMed Journal: Neurosurg Clin N Am ISSN: 1042-3680 Impact factor: 2.509